“CO34 | Evaluation of Emicizumab Concentration and Thrombin Generation in a Cohort of Severe Hemophilia A Patients With and Without Inhibitor: A. Taglietti1, S. Ligia1, F. Paoletti1, R. Mormile1, E. Baldacci2, A. Chistolini1, C. Santoro1,2 | 1Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma; 2Hematology, Azienda Ospedaliera Universitaria Policlinico Umberto I, Roma, Italy”. 2025. Bleeding, Thrombosis and Vascular Biology 4 (s1). https://doi.org/10.4081/btvb.2025.241.